Growth Metrics

Novartis Ag (NVS) Change in Acquisitions & Divestments (2019 - 2026)

Novartis Ag's Change in Acquisitions & Divestments history spans 9 years, with the latest figure at $37.0 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 48.0% to $37.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $221.0 million, a 75.95% decrease, with the full-year FY2025 number at $209.0 million, down 78.16% from a year prior.
  • Change in Acquisitions & Divestments hit $37.0 million in Q1 2026 for Novartis Ag, up from $24.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for NVS hit a ceiling of $647.0 million in Q2 2024 and a floor of $12.0 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $99.1 million across 5 years, with a median of $47.0 million in 2023.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 1276.6% in 2024 and later tumbled 96.91% in 2025.
  • Tracing NVS's Change in Acquisitions & Divestments over 5 years: stood at $12.0 million in 2022, then soared by 1125.0% to $147.0 million in 2023, then crashed by 85.71% to $21.0 million in 2024, then grew by 14.29% to $24.0 million in 2025, then skyrocketed by 54.17% to $37.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for NVS at $37.0 million in Q1 2026, $24.0 million in Q4 2025, and $140.0 million in Q3 2025.